FDA Inspection 1195256 — Genesis Biosystems, Inc

Genesis Biosystems, Inc — FEI 3003427273

The FDA completed an inspection of Genesis Biosystems, Inc on Jan 9, 2023 in Lewisville, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 9, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Lewisville, TX (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472021 CFR 820.50(a)(3)Acceptable supplier records, inadequate records
232821 CFR 820.22Quality audits - auditor independence

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.